Systemic, allogenic stem cell therapies for treatment of diseases in equines
OwnerErik John Woods, Shelly J. Zacharias +1inventors
InventorsErik John Woods, Shelly J. Zacharias, Sreedhar Thirumala
Life of this patent
Estimating the term…
Abstract
A method for treating preselected diseases comprising the steps of providing a therapeutic dose of a mesenchymal stem cell composition, the mesenchymal stem cell composition comprising mesenchymal stem cells harvested from at least one tissue selected from the group consisting of placental tissue, bone marrow, dental tissue, testicle tissue, and dermal tissue; and systemically administering the mesenchymal stem cell composition to the patient suffering from a preselected disease or diseased state through an intravenous injection.
Claims17
A method for treating an equine patient suffering from a disease or diseased state, comprising the step of administering a therapeutic dose of a mesenchymal stem cell composition through an intravenous injection, the mesenchymal stem cell composition comprising mesenchymal stem cells harvested from at least one tissue selected from the group consisting of:
- placental tissue, uterine tissue, bone marrow, dental tissue, testicular tissue, umbilical cord tissue, and skin tissue.
A mesenchymal stem cell composition comprising:
- a. at least 6 million equine mesenchymal stem cells derived from progenitor cells harvested from placental tissue, bone marrow, dental tissue, testicle tissue, uterine tissue, umbilical cord tissue, or skin tissue;
- and
- b. a saline solution, wherein the composition has a maximum concentration of about 500,000 cells per mL.
Dependencies are inferred from the claim text.